172 related articles for article (PubMed ID: 38204183)
1. From Alzheimer's disease to vascular dementia: Different roads leading to cognitive decline.
Semerano A; Fernández-Ruiz J; Cortes-Canteli M; Moro MA
Br J Pharmacol; 2024 Mar; 181(6):755-759. PubMed ID: 38204183
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?
García-Culebras A; Cuartero MI; Peña-Martínez C; Moraga A; Vázquez-Reyes S; de Castro-Millán FJ; Cortes-Canteli M; Lizasoain I; Moro MÁ
Br J Pharmacol; 2024 Mar; 181(6):777-798. PubMed ID: 37282844
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease.
Bettinetti-Luque M; Trujillo-Estrada L; Garcia-Fuentes E; Andreo-Lopez J; Sanchez-Varo R; Garrido-Sánchez L; Gómez-Mediavilla Á; López MG; Garcia-Caballero M; Gutierrez A; Baglietto-Vargas D
Br J Pharmacol; 2024 Mar; 181(6):840-878. PubMed ID: 37706346
[TBL] [Abstract][Full Text] [Related]
4. The role of gut microbiota in cerebrovascular disease and related dementia.
Cuartero MI; García-Culebras A; Nieto-Vaquero C; Fraga E; Torres-López C; Pradillo J; Lizasoain I; Moro MÁ
Br J Pharmacol; 2024 Mar; 181(6):816-839. PubMed ID: 37328270
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulants: A plausible new treatment for Alzheimer's disease?
Toribio-Fernandez R; Ceron C; Tristão-Pereira C; Fernandez-Nueda I; Perez-Castillo A; Fernandez-Ferro J; Moro MA; Ibañez B; Fuster V; Cortes-Canteli M
Br J Pharmacol; 2024 Mar; 181(6):760-776. PubMed ID: 36633908
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms linking cerebrovascular dysfunction and tauopathy: Adding a layer of epiregulatory complexity.
Kim YA; Mellen M; Kizil C; Santa-Maria I
Br J Pharmacol; 2024 Mar; 181(6):879-895. PubMed ID: 37926507
[TBL] [Abstract][Full Text] [Related]
7. Update on the role of T cells in cognitive impairment.
Ruiz-Fernández I; Sánchez-Díaz R; Ortega-Sollero E; Martín P
Br J Pharmacol; 2024 Mar; 181(6):799-815. PubMed ID: 37559406
[TBL] [Abstract][Full Text] [Related]
8. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.
Duce JA; Zhu X; Jacobson LH; Beart PM
Br J Pharmacol; 2019 Sep; 176(18):3409-3412. PubMed ID: 31468515
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-derived lactoferrin reduces β-amyloid burden by promoting the interaction between p38 kinase and PP2A phosphatase in male APP/PS1 transgenic mice.
Fan YG; Guo C; Zhao LX; Ge RL; Pang ZQ; He DL; Ren H; Wu TY; Zhang YH; Wang ZY
Br J Pharmacol; 2024 Mar; 181(6):896-913. PubMed ID: 37309219
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
Ittner LM; Klugmann M; Ke YD
Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
[TBL] [Abstract][Full Text] [Related]
11. Editorial for GPR84 pharmacology.
Milligan G
Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
[TBL] [Abstract][Full Text] [Related]
12. Platelet purinergic receptors and non-thrombotic diseases.
Pitchford SC; Pan D
Br J Pharmacol; 2024 Feb; 181(4):513-514. PubMed ID: 38093587
[TBL] [Abstract][Full Text] [Related]
13. Treating Alzheimer's disease by targeting iron.
Nikseresht S; Bush AI; Ayton S
Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
[TBL] [Abstract][Full Text] [Related]
14. The involvement of microglia in Alzheimer's disease: a new dog in the fight.
Moore Z; Taylor JM; Crack PJ
Br J Pharmacol; 2019 Sep; 176(18):3533-3543. PubMed ID: 30445661
[TBL] [Abstract][Full Text] [Related]
15. Multi-angle development of therapeutic methods for Alzheimer's disease.
Hoshi M
Br J Pharmacol; 2021 Feb; 178(4):770-783. PubMed ID: 32592177
[TBL] [Abstract][Full Text] [Related]
16. A short perspective on the long road to effective treatments for Alzheimer's disease.
Reynolds DS
Br J Pharmacol; 2019 Sep; 176(18):3636-3648. PubMed ID: 30657599
[TBL] [Abstract][Full Text] [Related]
17. Don't forget astrocytes when targeting Alzheimer's disease.
Sadick JS; Liddelow SA
Br J Pharmacol; 2019 Sep; 176(18):3585-3598. PubMed ID: 30636042
[TBL] [Abstract][Full Text] [Related]
18. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.
Perez Ortiz JM; Swerdlow RH
Br J Pharmacol; 2019 Sep; 176(18):3489-3507. PubMed ID: 30675901
[TBL] [Abstract][Full Text] [Related]
20. Role of phytochemicals as nutraceuticals for cognitive functions affected in ageing.
Howes MR; Perry NSL; Vásquez-Londoño C; Perry EK
Br J Pharmacol; 2020 Mar; 177(6):1294-1315. PubMed ID: 31650528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
